1. Home
  2. SCNI vs APDN Comparison

SCNI vs APDN Comparison

Compare SCNI & APDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCNI
  • APDN
  • Stock Information
  • Founded
  • SCNI 2003
  • APDN 1983
  • Country
  • SCNI Israel
  • APDN United States
  • Employees
  • SCNI N/A
  • APDN N/A
  • Industry
  • SCNI Biotechnology: Biological Products (No Diagnostic Substances)
  • APDN Other Consumer Services
  • Sector
  • SCNI Health Care
  • APDN Consumer Discretionary
  • Exchange
  • SCNI Nasdaq
  • APDN Nasdaq
  • Market Cap
  • SCNI 1.5M
  • APDN 1.7M
  • IPO Year
  • SCNI N/A
  • APDN N/A
  • Fundamental
  • Price
  • SCNI $1.57
  • APDN $2.90
  • Analyst Decision
  • SCNI
  • APDN
  • Analyst Count
  • SCNI 0
  • APDN 0
  • Target Price
  • SCNI N/A
  • APDN N/A
  • AVG Volume (30 Days)
  • SCNI 324.3K
  • APDN 68.6K
  • Earning Date
  • SCNI 09-16-2025
  • APDN 08-26-2025
  • Dividend Yield
  • SCNI N/A
  • APDN N/A
  • EPS Growth
  • SCNI N/A
  • APDN N/A
  • EPS
  • SCNI N/A
  • APDN 211.51
  • Revenue
  • SCNI $1,147,000.00
  • APDN $3,743,063.00
  • Revenue This Year
  • SCNI N/A
  • APDN $57.08
  • Revenue Next Year
  • SCNI N/A
  • APDN $40.00
  • P/E Ratio
  • SCNI $4.25
  • APDN $0.01
  • Revenue Growth
  • SCNI N/A
  • APDN 55.60
  • 52 Week Low
  • SCNI $1.40
  • APDN $2.81
  • 52 Week High
  • SCNI $6.18
  • APDN $1,410.00
  • Technical
  • Relative Strength Index (RSI)
  • SCNI 45.14
  • APDN 26.11
  • Support Level
  • SCNI $1.46
  • APDN $2.81
  • Resistance Level
  • SCNI $1.68
  • APDN $3.30
  • Average True Range (ATR)
  • SCNI 0.12
  • APDN 0.23
  • MACD
  • SCNI 0.03
  • APDN -0.02
  • Stochastic Oscillator
  • SCNI 33.33
  • APDN 7.09

About SCNI Scinai Immunotherapeutics Ltd.

Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units, one focused on in-house development of inflammation and immunology (I&I) biological therapeutic products beginning with a pipeline of nanosized VHH antibodies (NanoAbs) targeting diseases with large unmet medical needs, and the other a boutique CDMO providing services to help biotech companies efficiently bring their products to market by leveraging Scinai's drug development and GMP and non-GMP manufacturing capabilities for pre-clinical and clinical studies. The company generates maximum revenue from the provision of CDMO (Contract Development and Manufacturing Organization) services.

About APDN Applied DNA Sciences Inc.

Applied DNA Sciences Inc is a biotechnology company developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The company operates in three business segments- Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. It generates majority of its revenue from the MDx Testing Services which is involved in performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. The company provides its products and services under the brand of Applied DNA Sciences, SigNature molecular tags, SigNature T molecular tags, fiberTyping, SigNify and others.

Share on Social Networks: